Are restraints on drug price increases doomed by pharma lobbying?

Are restraints on drug price increases doomed by pharma lobbying?

Are reasonable restraints on drug price increases doomed by pharma lobbying?

By ALFRED ENGELBERG

ADOBE

Drug price increases have been on a runaway upward trend. A bill to cap prices based on inflation could stop that, but likely won't survive pharma lobbying.

READ MORE